Sweden· SE-19880108000014
Andapsin 1 g/5 ml Oral suspension i dospåse
A medicinal product containing sucralfate, registered in Sweden by Orion Corporation.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Sucralfate
- Manufacturer
- Orion Corporation
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer19880108000014
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sucralfate in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayAntepsinOrion Corporation Orion Pharma
- FinlandAntepsinOrion Corporation
- United StatesCarafateAllergan, Inc.
- United KingdomAntepsin 1g tabletsChugai Pharma UK Ltd
- ItalyANTEPSINLABORATORI BALDACCI S.P.A.
- CanadaAPO-SUCRALFATE - TAB 1GAPOTEX INC
- FranceKEAL 1 g, comprimé sécableEXOD
- NetherlandsPeptonorm 1 g, tablettenUni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Sucralan, Sucralfat Genericon
- Germany · Sucrabest
- Denmark · Antepsin, Peptonorm
- Finland · Antepsin, Peptonorm
- France · Keal, Ulcar
- United Kingdom (Northern Ireland) · Sucralfate Roma Pharmaceuticals
- Greece · Peptonorm
- Hungary · Peptonorm
- Iceland · Antepsin
- Italy · Antepsin, Sucralfato Doc Generici
- Netherlands · Sucralfaat Sandoz, Sucralfaat Teva
- Norway · Antepsin
- Portugal · Sucralfato Generis, Sucralfato Jaba
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1bac2c7d-0bac-406f-ac92-cc10d99efd21 GET /v1/drugs/1bac2c7d-0bac-406f-ac92-cc10d99efd21?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL"
],
"se_npl_id": "19880108000014",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19880108000014",
"product_doc_link": "https://docetp.mpa.se/LMF/Andapsin%20tablet%2C%20oral%20suspension%20SmPC_09001bee807a2e6f.pdf"
}See everything about sucralfate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.